Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cytokinetics (CYTK) Revenue: 2009-2024

Historic Revenue for Cytokinetics (CYTK) over the last 16 years, with Dec 2024 value amounting to $15.0 million.

  • Cytokinetics' Revenue rose 318.14% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $85.3 million, marking a year-over-year increase of 2549.39%. This contributed to the annual value of $15.0 million for FY2024, which is 99.20% up from last year.
  • Latest data reveals that Cytokinetics reported Revenue of $15.0 million as of FY2024, which was up 99.20% from $7.5 million recorded in FY2023.
  • Cytokinetics' Revenue's 5-year high stood at $94.6 million during FY2022, with a 5-year trough of $7.5 million in FY2023.
  • In the last 3 years, Cytokinetics' Revenue had a median value of $15.0 million in 2024 and averaged $39.0 million.
  • Its Revenue has fluctuated over the past 5 years, first slumped by 92.04% in 2023, then spiked by 99.20% in 2024.
  • Over the past 5 years, Cytokinetics' Revenue (Yearly) stood at $36.5 million in 2020, then spiked by 50.41% to $54.9 million in 2021, then skyrocketed by 72.29% to $94.6 million in 2022, then tumbled by 92.04% to $7.5 million in 2023, then soared by 99.20% to $15.0 million in 2024.